| abstract |
A pharmaceutical composition for the treatment of Parkinson's disease, said composition comprising a pharmaceutically acceptable carrier and a combination of two active agents at defined doses, wherein the active agent is administered to a patient suffering from Parkinson's disease with a neuroprotective or analgesic effect, And a compound having a prominent effect, wherein the molar ratio of the two compounds is 1: 1 to 1: 100. The compositions are formulated in an immediate release, controlled release, or immediate and controlled release form. |